ACADIA Pharmaceuticals (ACAD) Competitors $16.27 +0.06 (+0.37%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ACAD vs. BHC, ARWR, MRTX, RARE, IONS, CTLT, SRPT, RVMD, QGEN, and ITCIShould you be buying ACADIA Pharmaceuticals stock or one of its competitors? The main competitors of ACADIA Pharmaceuticals include Bausch Health Companies (BHC), Arrowhead Pharmaceuticals (ARWR), Mirati Therapeutics (MRTX), Ultragenyx Pharmaceutical (RARE), Ionis Pharmaceuticals (IONS), Catalent (CTLT), Sarepta Therapeutics (SRPT), Revolution Medicines (RVMD), Qiagen (QGEN), and Intra-Cellular Therapies (ITCI). These companies are all part of the "medical" sector. ACADIA Pharmaceuticals vs. Bausch Health Companies Arrowhead Pharmaceuticals Mirati Therapeutics Ultragenyx Pharmaceutical Ionis Pharmaceuticals Catalent Sarepta Therapeutics Revolution Medicines Qiagen Intra-Cellular Therapies ACADIA Pharmaceuticals (NASDAQ:ACAD) and Bausch Health Companies (NYSE:BHC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation. Do analysts recommend ACAD or BHC? ACADIA Pharmaceuticals currently has a consensus target price of $25.56, indicating a potential upside of 57.11%. Bausch Health Companies has a consensus target price of $7.75, indicating a potential downside of 5.43%. Given ACADIA Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts clearly believe ACADIA Pharmaceuticals is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ACADIA Pharmaceuticals 0 Sell rating(s) 6 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.65Bausch Health Companies 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community prefer ACAD or BHC? ACADIA Pharmaceuticals received 534 more outperform votes than Bausch Health Companies when rated by MarketBeat users. Likewise, 73.20% of users gave ACADIA Pharmaceuticals an outperform vote while only 61.47% of users gave Bausch Health Companies an outperform vote. CompanyUnderperformOutperformACADIA PharmaceuticalsOutperform Votes89373.20% Underperform Votes32726.80% Bausch Health CompaniesOutperform Votes35961.47% Underperform Votes22538.53% Is ACAD or BHC more profitable? ACADIA Pharmaceuticals has a net margin of 13.83% compared to Bausch Health Companies' net margin of -1.88%. ACADIA Pharmaceuticals' return on equity of 25.83% beat Bausch Health Companies' return on equity.Company Net Margins Return on Equity Return on Assets ACADIA Pharmaceuticals13.83% 25.83% 14.71% Bausch Health Companies -1.88%-755.86%5.11% Does the media favor ACAD or BHC? In the previous week, ACADIA Pharmaceuticals had 18 more articles in the media than Bausch Health Companies. MarketBeat recorded 20 mentions for ACADIA Pharmaceuticals and 2 mentions for Bausch Health Companies. Bausch Health Companies' average media sentiment score of 1.19 beat ACADIA Pharmaceuticals' score of 0.04 indicating that Bausch Health Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ACADIA Pharmaceuticals 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Bausch Health Companies 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of ACAD or BHC? 96.7% of ACADIA Pharmaceuticals shares are owned by institutional investors. Comparatively, 78.7% of Bausch Health Companies shares are owned by institutional investors. 28.3% of ACADIA Pharmaceuticals shares are owned by insiders. Comparatively, 8.1% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher earnings and valuation, ACAD or BHC? ACADIA Pharmaceuticals has higher earnings, but lower revenue than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than ACADIA Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioACADIA Pharmaceuticals$726.44M3.73-$61.29M$0.7820.86Bausch Health Companies$8.76B0.34-$592M-$0.48-17.07 Which has more volatility and risk, ACAD or BHC? ACADIA Pharmaceuticals has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. SummaryACADIA Pharmaceuticals beats Bausch Health Companies on 15 of the 18 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACAD vs. The Competition Export to ExcelMetricACADIA PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.71B$6.48B$5.05B$8.87BDividend YieldN/A8.12%4.97%4.06%P/E Ratio20.865.5697.3414.18Price / Sales3.73348.141,218.4289.42Price / CashN/A22.1533.5132.79Price / Book6.197.885.805.12Net Income-$61.29M$153.61M$119.07M$225.99M7 Day Performance-4.41%-2.00%-1.83%-1.32%1 Month Performance10.23%-7.47%-3.64%0.60%1 Year Performance-27.53%31.80%31.62%26.23% ACADIA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACADACADIA Pharmaceuticals3.9106 of 5 stars$16.27+0.4%$25.56+57.1%-29.0%$2.71B$726.44M20.86510Insider TradeAnalyst RevisionBHCBausch Health Companies3.4347 of 5 stars$8.20+0.1%$7.75-5.4%+16.3%$3.01B$8.76B-17.0720,270Positive NewsARWRArrowhead Pharmaceuticals3.5698 of 5 stars$18.71+0.6%$45.33+142.3%-35.3%$2.31B$240.74M0.00400Upcoming EarningsAnalyst ForecastMRTXMirati Therapeutics0.5607 of 5 stars$58.70flat$59.00+0.5%N/A$4.12B$12.44M-4.80587Analyst ForecastRAREUltragenyx Pharmaceutical4.6401 of 5 stars$46.40+2.8%$86.69+86.8%+17.9%$4.17B$434.25M0.001,276IONSIonis Pharmaceuticals4.2197 of 5 stars$35.40+4.9%$60.65+71.3%-28.7%$5.33B$788M0.00800CTLTCatalent3.03 of 5 stars$59.00+0.2%$63.40+7.5%+47.8%$10.71B$4.38B-26.1116,900SRPTSarepta Therapeutics4.9373 of 5 stars$110.86+4.0%$181.33+63.6%+33.5%$10.18B$1.64B88.691,314Analyst DowngradeGap UpRVMDRevolution Medicines2.7869 of 5 stars$57.07+1.1%$61.00+6.9%+162.6%$9.50B$11.58M0.00443QGENQiagen4.4347 of 5 stars$42.11+3.2%$50.88+20.8%+2.5%$9.31B$1.97B107.975,967Positive NewsHigh Trading VolumeITCIIntra-Cellular Therapies4.4721 of 5 stars$85.64+2.7%$97.23+13.5%+46.2%$8.84B$464.37M0.00560Positive News Related Companies and Tools Related Companies Bausch Health Companies Alternatives Arrowhead Pharmaceuticals Alternatives Mirati Therapeutics Alternatives Ultragenyx Pharmaceutical Alternatives Ionis Pharmaceuticals Alternatives Catalent Alternatives Sarepta Therapeutics Alternatives Revolution Medicines Alternatives Qiagen Alternatives Intra-Cellular Therapies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACAD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
